Daiwa Securities Group Inc. - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 197 filers reported holding MYRIAD GENETICS INC in Q1 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$5
-37.5%
3260.0%0.00%
Q2 2023$80.0%3260.0%0.00%
Q1 2023$8
+60.0%
3260.0%0.00%
Q4 2022$5
-99.9%
326
+22.1%
0.00%
Q3 2022$5,0000.0%2670.0%0.00%
Q2 2022$5,000
-28.6%
2670.0%0.00%
Q1 2022$7,0000.0%2670.0%0.00%
Q4 2021$7,000
-22.2%
2670.0%0.00%
Q3 2021$9,000
+125.0%
267
+89.4%
0.00%
Q2 2021$4,0000.0%1410.0%0.00%
Q1 2021$4,000
+33.3%
1410.0%0.00%
Q4 2020$3,000
-40.0%
141
-66.4%
0.00%
Q3 2020$5,000
-16.7%
4200.0%0.00%
Q2 2020$6,0000.0%4200.0%0.00%
Q1 2020$6,000
-45.5%
4200.0%0.00%
Q4 2019$11,000
-15.4%
420
-9.9%
0.00%
Q3 2019$13,0000.0%4660.0%0.00%
Q2 2019$13,000
-13.3%
4660.0%0.00%
Q1 2019$15,000
+36.4%
466
+21.7%
0.00%
Q4 2018$11,000
-38.9%
3830.0%0.00%
Q3 2018$18,000
+28.6%
3830.0%0.00%
Q2 2018$14,000
+27.3%
3830.0%0.00%
Q1 2018$11,000
-99.6%
383
-99.6%
0.00%
-100.0%
Q1 2014$3,077,00090,0000.02%
Other shareholders
MYRIAD GENETICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Camber Capital Management LP 5,000,000$90,850,0003.94%
Altium Capital Management LP 221,000$4,016,0001.61%
DISCIPLINED GROWTH INVESTORS INC /MN 1,900,787$34,537,0000.93%
Zebra Capital Management LLC 15,352$279,0000.82%
PFM Health Sciences, LP 1,177,250$21,391,0000.82%
EARNEST PARTNERS LLC 6,462,138$117,417,0000.78%
Glenview Capital Management 1,696,791$30,831,0000.77%
AIMZ Investment Advisors, LLC 42,085$765,0000.37%
Phocas Financial Corp. 127,949$2,325,0000.35%
Redhawk Wealth Advisors, Inc. 34,680$630,0000.29%
View complete list of MYRIAD GENETICS INC shareholders